Derek Archila
Stock Analyst at Wells Fargo
(4.87)
# 341
Out of 4,835 analysts
937
Total ratings
56.1%
Success rate
20.2%
Average return
Main Sectors:
Stocks Rated by Derek Archila
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PYXS Pyxis Oncology | Reiterated: Buy | $12 → $19 | $3.21 | +491.90% | 3 | Sep 10, 2026 | |
| ALMS Alumis | Reiterated: Buy | $25 | $9.18 | +172.33% | 12 | Sep 9, 2026 | |
| SEPN Septerna | Reiterated: Buy | $50 | $38.51 | +29.84% | 14 | Sep 9, 2026 | |
| XFOR X4 Pharmaceuticals | Reiterated: Buy | $11 | $3.50 | +214.29% | 2 | Sep 9, 2026 | |
| KYTX Kyverna Therapeutics | Reiterated: Buy | $33 | $7.26 | +354.55% | 15 | Sep 1, 2026 | |
| NRIX Nurix Therapeutics | Reiterated: Hold | $25 | $25.61 | -2.36% | 25 | Sep 1, 2026 | |
| KYMR Kymera Therapeutics | Rated: Buy | $116 → $151 | $116.47 | +29.65% | 25 | Aug 27, 2026 | |
| ARGX argenx SE | Rated: Buy | $1,350 → $1,415 | $984.39 | +43.74% | 79 | Aug 26, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $326 | $263.52 | +23.71% | 45 | Aug 14, 2026 | |
| ANNX Annexon | Reiterated: Buy | $27 | $3.94 | +585.28% | 22 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $3.51 | +184.90% | 14 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 → $102 | $72.44 | +40.81% | 7 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $1 | $0.4298 | +132.67% | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $72 | $36.90 | +95.12% | 23 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $116 | $121.47 | -4.50% | 41 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $59 | $11.10 | +431.53% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $11 | $8.45 | +30.18% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $12.04 | +107.64% | 13 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $55 | $36.44 | +50.93% | 3 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 | $21.24 | +45.95% | 19 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 | $104.00 | +49.04% | 61 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $14.07 | +106.11% | 17 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $37.36 | +20.45% | 29 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.94 | +157.73% | 1 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $78 → $79 | $70.06 | +12.76% | 4 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $35 | $56.12 | -37.63% | 26 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $479 → $376 | $248.68 | +51.20% | 4 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $81 | $53.87 | +50.36% | 27 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $56 | $68.01 | -17.66% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $66.74 | -53.55% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 | $66.06 | +10.51% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $29.05 | +247.68% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $30 | $16.86 | n/a | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $2.73 | n/a | 16 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $26.24 | n/a | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $3.51 | n/a | 17 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $56.28 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $11.07 | $1.28 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $2.11 | n/a | 11 | Jun 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $0.3155 | n/a | 34 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $8.19 | n/a | 20 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $42.31 | n/a | 27 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $96 → $97 | $26.84 | n/a | 15 | May 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $126 → $130 | $534.41 | n/a | 10 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $6 | $11.85 | n/a | 20 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $13.80 | n/a | 28 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $31.98 | n/a | 11 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €15.50 → €16.36 | €3.40 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $19 | $4.02 | n/a | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €90.25 → €96.00 | €23.32 | n/a | 2 | Feb 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €11.00 | €13.02 | n/a | 7 | Sep 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $25.22 | n/a | 14 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.09 | n/a | 31 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $12.01 | n/a | 12 | Apr 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.0004 | n/a | 11 | Mar 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 | $13.66 | n/a | 6 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $37.09 | n/a | 18 | Feb 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.8117 | n/a | 8 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.51 | n/a | 1 | Oct 3, 2017 |
Pyxis Oncology
Sep 10, 2026
Reiterated: Buy
Price Target: $12 → $19
Current: $3.21
Upside: +491.90%
Alumis
Sep 9, 2026
Reiterated: Buy
Price Target: $25
Current: $9.18
Upside: +172.33%
Septerna
Sep 9, 2026
Reiterated: Buy
Price Target: $50
Current: $38.51
Upside: +29.84%
X4 Pharmaceuticals
Sep 9, 2026
Reiterated: Buy
Price Target: $11
Current: $3.50
Upside: +214.29%
Kyverna Therapeutics
Sep 1, 2026
Reiterated: Buy
Price Target: $33
Current: $7.26
Upside: +354.55%
Nurix Therapeutics
Sep 1, 2026
Reiterated: Hold
Price Target: $25
Current: $25.61
Upside: -2.36%
Kymera Therapeutics
Aug 27, 2026
Rated: Buy
Price Target: $116 → $151
Current: $116.47
Upside: +29.65%
argenx SE
Aug 26, 2026
Rated: Buy
Price Target: $1,350 → $1,415
Current: $984.39
Upside: +43.74%
Ascendis Pharma
Aug 14, 2026
Reiterated: Buy
Price Target: $326
Current: $263.52
Upside: +23.71%
Annexon
Aug 13, 2026
Reiterated: Buy
Price Target: $27
Current: $3.94
Upside: +585.28%
Aug 12, 2026
Rated: Buy
Price Target: $10
Current: $3.51
Upside: +184.90%
Aug 11, 2026
Reiterated: Buy
Price Target: $98 → $102
Current: $72.44
Upside: +40.81%
Aug 10, 2026
Rated: Hold
Price Target: $1
Current: $0.4298
Upside: +132.67%
Aug 6, 2026
Reiterated: Buy
Price Target: $72
Current: $36.90
Upside: +95.12%
Aug 6, 2026
Reiterated: Hold
Price Target: $116
Current: $121.47
Upside: -4.50%
Aug 6, 2026
Reiterated: Buy
Price Target: $66 → $59
Current: $11.10
Upside: +431.53%
Aug 5, 2026
Downgraded: Hold
Price Target: $15 → $11
Current: $8.45
Upside: +30.18%
Aug 4, 2026
Reiterated: Buy
Price Target: $25
Current: $12.04
Upside: +107.64%
Jul 28, 2026
Reiterated: Buy
Price Target: $30 → $55
Current: $36.44
Upside: +50.93%
Jul 20, 2026
Rated: Buy
Price Target: $31
Current: $21.24
Upside: +45.95%
Jul 16, 2026
Rated: Buy
Price Target: $155
Current: $104.00
Upside: +49.04%
Jun 24, 2026
Rated: Buy
Price Target: $29
Current: $14.07
Upside: +106.11%
May 21, 2026
Reiterated: Buy
Price Target: $45
Current: $37.36
Upside: +20.45%
Mar 19, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.94
Upside: +157.73%
Mar 2, 2026
Reiterated: Buy
Price Target: $78 → $79
Current: $70.06
Upside: +12.76%
Feb 11, 2026
Reiterated: Hold
Price Target: $30 → $35
Current: $56.12
Upside: -37.63%
Jan 20, 2026
Reiterated: Hold
Price Target: $479 → $376
Current: $248.68
Upside: +51.20%
Dec 16, 2025
Reiterated: Buy
Price Target: $51 → $81
Current: $53.87
Upside: +50.36%
Dec 16, 2025
Reiterated: Sell
Price Target: $56
Current: $68.01
Upside: -17.66%
Oct 17, 2025
Reiterated: Buy
Price Target: $31
Current: $66.74
Upside: -53.55%
Oct 17, 2025
Reiterated: Buy
Price Target: $73
Current: $66.06
Upside: +10.51%
Oct 17, 2025
Reiterated: Buy
Price Target: $101
Current: $29.05
Upside: +247.68%
Aug 12, 2025
Reiterated: Hold
Price Target: $40 → $30
Current: $16.86
Upside: n/a
Aug 8, 2025
Reiterated: Hold
Price Target: $3 → $2
Current: $2.73
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $14
Current: $26.24
Upside: n/a
Aug 6, 2025
Reiterated: Hold
Price Target: $6 → $5
Current: $3.51
Upside: n/a
Dec 6, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $56.28
Upside: n/a
Dec 6, 2021
Initiated Coverage: Sell
Price Target: $11.07
Current: $1.28
Upside: n/a
Jun 13, 2021
Rated: Buy
Price Target: $12
Current: $2.11
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $27
Current: $0.3155
Upside: n/a
May 13, 2021
Reiterated: Hold
Price Target: $3
Current: $8.19
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $30
Current: $42.31
Upside: n/a
May 9, 2021
Reiterated: Hold
Price Target: $96 → $97
Current: $26.84
Upside: n/a
May 6, 2021
Reiterated: Hold
Price Target: $126 → $130
Current: $534.41
Upside: n/a
May 3, 2021
Reiterated: Hold
Price Target: $7 → $6
Current: $11.85
Upside: n/a
Apr 29, 2021
Reiterated: Hold
Price Target: $6
Current: $13.80
Upside: n/a
Apr 28, 2021
Reiterated: Buy
Price Target: $13
Current: $31.98
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: €15.50 → €16.36
Current: €3.40
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $18 → $19
Current: $4.02
Upside: n/a
Feb 19, 2021
Reiterated: Hold
Price Target: €90.25 → €96.00
Current: €23.32
Upside: n/a
Sep 30, 2020
Reiterated: Buy
Price Target: €11.00
Current: €13.02
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $25.22
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $5.09
Upside: n/a
Apr 2, 2018
Reiterated: Buy
Price Target: $13
Current: $12.01
Upside: n/a
Mar 22, 2018
Reiterated: Buy
Price Target: n/a
Current: $0.0004
Upside: n/a
Mar 5, 2018
Reiterated: Buy
Price Target: $98
Current: $13.66
Upside: n/a
Feb 8, 2018
Rated: Hold
Price Target: n/a
Current: $37.09
Upside: n/a
Nov 9, 2017
Reiterated: Hold
Price Target: n/a
Current: $0.8117
Upside: n/a
Oct 3, 2017
Reiterated: Hold
Price Target: n/a
Current: $16.51
Upside: n/a